Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MPI | P34949 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6759189 | 1.00 | MPI (0.39) | MPI | |
| SCHEMBL5453964 | 1.00 | MPI (0.39) | MPI | |
| SCHEMBL20280850 | 1.00 | MPI (0.39) | MPI | |
| SCHEMBL1586372 | 1.00 | MPI (0.39) | MPI | |
| SCHEMBL16344680 | 0.93 | MPI (0.41) | MPI | |
| SCHEMBL11063688 | 0.93 | MPI (0.41) | MPI | |
| SCHEMBL3441509 | 0.93 | MPI (0.41) | MPI | |
| SCHEMBL22323284 | 0.93 | MPI (0.41) | MPI | |
| SCHEMBL12289164 | 0.85 | MPI (0.37) | MPI | |
| SCHEMBL7149026 | 0.82 | MPI (0.36) | MPI |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 113 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250320175-A1 | Acetoacetate Based Ketals | ARXADA AG (CH) | 2025-10-16 | — | — | US | claimed |
| EP-4605371-A1 | POLYOL-DERIVED COMPOUNDS | Arxada AG (CH) | 2025-08-27 | — | — | EP | claimed |
| WO-2025074001-A2 | ENZYMATIC REDUCTION OF ACETOACETATE | ARXADA AG (CH) | 2025-04-10 | — | — | WO | claimed |
| US-20250066408-A1 | Polyol-Derived Compounds | ARXADA AG (CH) | 2025-02-27 | — | — | US | claimed |
| US-20250002446-A1 | Acetoacetate Based Ketals | ARXADA AG (CH) | 2025-01-02 | — | — | US | claimed |
| US-20240336646-A1 | Polyol-Derived Compounds | ARXADA AG (CH) | 2024-10-10 | — | — | US | claimed |
| CN-118591523-A | Polyol-derived compounds | 阿萨达股份公司 | 2024-09-03 | — | — | CN | claimed |
| EP-4412987-A1 | ACETOACETATE BASED KETALS | Arxada AG (CH) | 2024-08-14 | — | — | EP | claimed |
| EP-4405324-A1 | POLYOL-DERIVED COMPOUNDS | Arxada AG (CH) | 2024-07-31 | — | — | EP | claimed |
| WO-2024083889-A1 | POLYOL-DERIVED COMPOUNDS | ARXADA AG (CH) | 2024-04-25 | — | — | WO | claimed |
| WO-2023094654-A1 | ACETOACETATE BASED KETALS | ARXADA AG (CH) | 2023-06-01 | — | — | WO | claimed |
| WO-2023083570-A1 | POLYOL-DERIVED COMPOUNDS | ARXADA AG (CH) | 2023-05-19 | — | — | WO | claimed |
| CN-100375755-C | Longleaf Grateloupia acuminata polysaccharide extract and its prepn and use | SHANGHAI TRADITIONAL CHINESE M (CN) | 2008-03-19 | — | — | CN | claimed |
| CN-101077356-A | Application for polysaccharide extraction of grateloupia filicina in preparing antitumor medicine and other medicines | UNIV SHANGHAI OF T C M (CN) | 2007-11-28 | — | — | CN | claimed |
| CN-1810842-A | Longleaf Grateloupia acuminata polysaccharide extract and its prepn and use | SHANGHAI TRADITIONAL CHINESE M (CN) | 2006-08-02 | — | — | CN | claimed |
| EP-0130054-B1 | NOVEL FRUCTOSYLTRANSFERASE, PROCESS FOR THE PREPARATION OF FRUCTOSYL DISACCHARIDES, AND A NOVEL HALOSUCROSE | TATE & LYLE PUBLIC LIMITED COMPANY (GB) | 1990-03-07 | — | — | EP | claimed |
| US-4617269-A | WITH TRANSFERASE ENZYMES DERIVED FROM BACILLUS | TATE & LYLE PUBLIC LIMITED COMPANY (GB) | 1986-10-14 | — | — | US | claimed |
| JP-5244908-A | — | — | None | — | — | JP | disclosed |
| US-4617269-A | WITH TRANSFERASE ENZYMES DERIVED FROM BACILLUS | TATE & LYLE PUBLIC LIMITED COMPANY (GB) | 1986-10-14 | — | — | US | disclosed |
| JP-H00892303-A | — | — | 0001-01-01 | — | — | JP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240336646-A1 | Polyol-Derived Compounds | PARG, SQLE, PARN | MPI 343/4885 |
| US-20250002446-A1 | Acetoacetate Based Ketals | KYAT1, KAT5, ALDOA | MPI 2295/4885 |
| US-20250320175-A1 | Acetoacetate Based Ketals | KYAT1, KAT5, ALDOA | MPI 2295/4885 |
| US-20250066408-A1 | Polyol-Derived Compounds | PARG, SQLE, PARN | MPI 343/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.